Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Trauma (Emergency, Injury, Surgery) | Family Medicine

Heart Attack (Myocardial Infarction) Clinical Trials

A listing of Heart Attack (Myocardial Infarction) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

Research Site
Birmingham Alabama 35294

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Mobile Alabama 36608

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

View More »

Pfizer Investigational Site
Athens Alabama 35611

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Athens Alabama 35611

A Phase 3 clinical study for patients with Cardiovascular Disease

Novartis Investigative Site
Birmingham Alabama 35235-3424

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Birmingham Alabama 35294-2041

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Birmingham Alabama 35209

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Pfizer Investigational Site
Birmingham Alabama 35233

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Birmingham Alabama 35294

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Cardiology, P.C.
Birmingham Alabama 35211

Patients are needed to participate in a clinical research study evaluating Sodium Alginate and Calcium Gluconate and Saline Solution for the treatment of Acute Myocardial Infarction, Congestive Heart Failure or ST-Elevation Myocardial Infarction

Research Site
Huntsville Alabama
Updated

A clinical research study for the treatment of Stable Coronary Artery Disease (CAD), Myocardial Infarction

Novartis Investigative Site
Huntsville Alabama 35801

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Pfizer Investigational Site
Huntsville Alabama 35801

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

GSK Investigational Site
Huntsville Alabama 35801

A Phase 3 clinical study for patients with Acute Coronary Syndrome

Novartis Investigative Site
Mobile Alabama 36617-2293

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Mobile Alabama 36604

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Mobile Alabama 36608

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Mobile Alabama

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Alaska

Novartis Investigative Site
Anchorage Alaska 99508

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Arizona

Research Site
Glendale Arizona 85306

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Phoenix Arizona 85018

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Tucson Arizona 85712

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

View More »

Mercy Gilbert and Chandler Medical Center
Gilbert Arizona 85224

A clinical research study of ALLOGENEIC MESENCHYMAL BONE MARROW CELLS for the treatment of ST Segment Elevation Myocardial Infarction (STEMI) or Allogeneic Mesenchymal Bone Marrow Cells

Novartis Investigative Site
Glendale Arizona 85302

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Pfizer Investigational Site
Glendale Arizona 85308

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Novartis Investigative Site
Phoenix Arizona 85032

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Phoenix Arizona 85018

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Pfizer Investigational Site
Tempe Arizona 85282

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Tempe Arizona 85282

A Phase 3 clinical study for patients with Cardiovascular Disease

Pfizer Investigational Site
Tucson Arizona 85710

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

GSK Investigational Site
Tucson Arizona 85724

A Phase 3 clinical study for patients with Acute Coronary Syndrome

Pfizer Investigational Site
Tucson Arizona 85710

A Phase 3 clinical study for patients with Cardiovascular Disease

Arkansas

Novartis Investigative Site
Hot Springs Arkansas 71913

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Novartis Investigative Site
Jonesboro Arkansas 72401

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Jonesboro Arkansas

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Novartis Investigative Site
Little Rock Arkansas 72204

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

California

Research Site
Banning California 92220

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Harbor City California 90710

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Laguna Hills California 92653

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Long Beach California 90807

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Newport Beach California 92663

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Oceanside California 92056

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Oxnard California 93030

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Palm Springs California 92262

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Roseville California 95661

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
San Pedro California 90732

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Tarzana California 91356

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Thousand Oaks California 91360

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Torrance California 90502

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Valley Village California 91607

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last